Home›Stock Screener›Aakaar Medical Technologies›Financial Statements

Aakaar Medical Technologies Complete Financial Statements

7 Years of Data
2026 - 2020

In FYNone, Aakaar Medical Technologies (AAKAAR) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 10.3% and ROE of 12.7%. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see AAKAAR share price.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 10.29% 2026 data
EBITDA Margin 16.18% 2026 data
Operating Margin 15.00% 2026 data
Return on Assets 8.86% 2026 data
Return on Equity 12.73% 2026 data

Balance Sheet Ratios

Current Ratio 77.00 2026 data
Equity Ratio 69.62% 2026 data
Asset Turnover 0.86 2026 data

AAKAAR Revenue, Net Profit & EBITDA — Year-on-Year Growth

AAKAAR YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. View AAKAAR annual price range for the annual high/low range and current price position.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+46.3%
Year-over-Year
Equity Growth
+139.1%
Year-over-Year
Operating Cash Flow Growth
-60.0%
Year-over-Year
Financing Cash Flow Growth
+72.7%
Year-over-Year

AAKAAR Income Statement — Revenue, EBITDA & Net Profit

Aakaar Medical Technologies revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 10.3%. Check Aakaar Medical Technologies market worth to track the company's total market size over time.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 0 68 62 46 33 20 13 23
Expenses 0 57 52 41 29 17 12 20
EBITDA 0 11 10 5 4 2 1 3
Operating Profit Margin % 0.00% 15.00% 16.00% 11.00% 11.00% 12.00% 7.00% 13.00%
Depreciation 0 0 0 0 0 0 0 0
Interest 0 2 2 1 0 0 0 1
Profit Before Tax 0 9 8 4 3 2 1 3
Tax 0 3 2 1 1 1 0 1
Net Profit 0 7 6 3 2 2 1 2
Earnings Per Share (₹) 0.00 4.99 6.12 3.15 2.37 1.78 54.44 182.79

AAKAAR Balance Sheet — Assets, Liabilities & Shareholders' Equity

AAKAAR total assets ₹79 Cr, total equity ₹55 Cr, total liabilities ₹ Cr (2026) — ROE 12.7%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 79 54 34 23 18 14 16
Current Assets 77 52 33 22 17 14 16
Fixed Assets 0 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0
Other Assets 79 54 34 23 18 14 16
LIABILITIES
Total Liabilities
Current Liabilities 1 1 1 1 1 4 6
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 55 23 13 10 8 7 7
Share Capital 14 10 1 1 1 0 0
Reserves & Surplus 40 13 12 9 7 7 7

AAKAAR Cash Flow Statement — Operating, Investing & Financing

Aakaar Medical Technologies operating cash flow ₹-8 Cr, investing ₹0 Cr, financing ₹19 Cr, net cash flow ₹11 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities -8 -5 -8 -3 1 4 0
Investing Activities 0 0 0 0 0 0 0
Financing Activities 19 11 8 1 -1 -2 0
Net Cash Flow 11 5 0 -2 -1 3 0